Capital World Investors Haemonetics Corp Transaction History

Capital World Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $18 Million - $22.1 Million	-313,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $50.5 Million - $116 Million	-974,600 Reduced 75.69%	313,000 $20.9 Million
Q1 2021 May 14, 2021	BUY	$111.01 - $139.48 $11.7 Million - $14.6 Million	105,000 Added 8.88%	1,287,600 $143 Million
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $30.8 Million - $41.6 Million	346,700 Added 41.48%	1,182,600 $140 Million
Q3 2020 Nov 13, 2020	BUY	$75.65 - $93.58 $16.3 Million - $20.2 Million	215,800 Added 34.8%	835,900 $72.9 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $28.7 Million - $40.2 Million	337,778 Added 119.64%	620,100 $55.5 Million
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $21 Million - $34.4 Million	282,322 New	282,322 $28.1 Million

337

54.3M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.05B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.